A Pilot Study Comparing the Efficacy of Lactate Dehydrogenase Levels Versus Circulating Cell-Free microRNAs in Monitoring Responses to Checkpoint Inhibitor Immunotherapy in Metastatic Melanoma Patients

SIMPLE SUMMARY: Improvement in melanoma patients with metastatic disease is needed to better assess immunotherapies. Lactate dehydrogenase (LDH) is currently an accepted biomarker for stage IV, but it has limited utility for stage III melanoma patients. Thus, finding biomarkers for metastatic melano...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancers (Basel)
Main Authors: Bustos, Matias A., Gross, Rebecca, Rahimzadeh, Negin, Cole, Hunter, Tran, Linh T., Tran, Kevin D., Takeshima, Ling, Stern, Stacey L., O’Day, Steven, Hoon, Dave S. B.
Format: Artigo
Sprog:Inglês
Udgivet: MDPI 2020
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7696545/
https://ncbi.nlm.nih.gov/pubmed/33202891
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12113361
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker